Seeking Alpha


Send Message
View as an RSS Feed
Latest  |  Highest rated
  • Gilead's Predicament: Revenue And Earnings Are Unsustainable [View article]
    I disagree with the author's argument. For 1 - for every one person cured of HCV per day there are probably another 20 infected globally (that is a speculation on my part). HVC is an epidemic and has been for many decades. The people learning they are infected now were infected many years ago in most cases haven't shown symptoms for decades and don't go to a Doctor until symptoms arise, often having infected many others over years. 2nd - Intravenous drug use is at an all time high and on the rise. Just ask the Governor of Kansas. Methamphetamine use is epidemic as is heroin. Gild has a business model that will last for years due to drug use alone probably for decades to come knowing the symptoms of HCV. GILD has the best cure on the market and the best cure in the near future according to cure rates, side effects and dosage, etc. Gild is also not a one trick pony with many other drugs on the market and in the pipeline. I am long on GILD from $64 and wish I'd gotten in 11 months earlier than that!
    Apr 28, 2015. 07:43 PM | 2 Likes Like |Link to Comment
  • The high cost of Gilead's Sovaldi giving Medicaid jaundice [View news story]
    Pay now or pay later when these people who could have been treated are in hospitals where insurance or Medicaid will pay a heck of a lot more for liver transplants ($375,000 average) or long-term terminal care (a lot more than $84,000 that is for sure!). Solvaldi saved my life post transplant when HEP C came back with a vengeance. Now that equals a transplant & post transplant treatment to prevent another transplant later. You do the math, go ahead, it is pretty easy to figure out. Pay now or ...
    Mar 5, 2014. 08:32 PM | 1 Like Like |Link to Comment
  • The high cost of Gilead's Sovaldi giving Medicaid jaundice [View news story]
    Pay now or pay later, insurance or Medicaid should think twice about balking at the costs of Gilead's treatment. Average liver transplants cost $375,000 or long-term terminal care costs are a lot more than the $84,000 for the Gilead treatment. I am post transplant with returning HEP C and had Gilead's treatment which cured the HEP C virus eliminating from my body. Costs? Transplant & treatment. No treatment? Another transplant in approximately 10 years or long term terminal care. Preventative treatment with Gilead? One time $84,000 - the math is pretty easy. Less costs for insurance or taxpayers with preventative Gilead treatment.
    Mar 5, 2014. 08:31 PM | 3 Likes Like |Link to Comment
  • Payers rebel against Gilead over cost of hepatitis C pill [View news story]
    I am a liver transplant patient who has been cured of Hep C by the Gilead drug therapy after the virus returned post transplant. The cost to my insurance company for the transplant and treatment is nearly $500,000 after several complications from the operation. Had the Gilead drug therapy been available in the 90's when Interferon and Rebavirin treatment failed to stop the virus, I would have never needed a transplant. That translates into savings of $416.000 for the insurance companies and years of my suffering, not to mention lost wages from time off, etc. With out the Gilead treatment now, it is inevitable I would need another transplant within 10 years or expensive hospital stays until my early demise, as the virus had begun to attack my new liver with a vengeance. I am LIVING proof that an ounce of prevention is worth a pound of cure!
    Jan 27, 2014. 07:39 PM | 1 Like Like |Link to Comment